期刊文献+

HPLC荧光法测定血浆替米沙坦浓度 被引量:4

Determination of Telmisartan in Plasma by HPLC with Fluorescent
下载PDF
导出
摘要 目的:建立高效液相-荧光检测法测定血浆替米沙坦浓度。方法:采用Symmetry C18柱,流动相:0.05 mol·L-1磷酸二氢钾溶液(用1 mol·L-1磷酸溶液调节pH=3.65):乙腈=55:45,激发波长:300 nm;发射波长:385 nm。结果:线性回归方程Y =0.055 80C-0.001 45,r=0.999 8;线性范围为1.0~500.0μg·L-1,最低检测限为1 μg·L-1。低、中、高三种浓度的绝对回收率分别为77.6%,94.97%和97.66%,相对回收率为96.62%,98.46%和104.43%,日内,日间RSD均小于10%。结论:该法操作简便,精密度高,可满足生物利用度试验方法学的要求。 Objective: To establish a HPLC for the determination of concentration of telmisartan in human plasma. Method: The samples were chromatographed on a symmetry-C18 reversed-phase column and monitered by fluorescene-detection at the EX300 and EM385 nm. The mobile phase consisted of 0. 05 mol·L-1 of potassium dihydrogen phosphate-acetonitrile(55:45,pH=3. 65) with a flow rate of 1. 0 ml·min-1. Result: The calibration curve was linear within a range of 1.0-500 μg·L-1 ( r = 0. 999 8). The RSD of in-tra-day and inter-day were less than 10% . The absolute recovery of three kinds of concentration were 96. 6% ,98. 46% , and 104. 43% , respectively. The limit of quantificaiton was 1 μg·L-1. Conclusion: This method had a good selectivity,sensitivity, and reproducibity. This method was shown to be suitable for pharmacokinetic study on telmisartan in human, and monitoring the plasma level of drug in clinic.
出处 《中国药师》 CAS 2005年第5期405-407,共3页 China Pharmacist
关键词 替米沙坦 高效液相色谱法 Telmisartan HPLC
  • 相关文献

参考文献4

  • 1Stangier J, Su CA, Roth W. Pharmacokinectics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients[J]. J Int Med Res,2000,28(4) :149-167. 被引量:1
  • 2Ebner T, Heiniel G, Prox A,et al. Disposition and chemical stability of telmisartan 1 - o - acylglucuronide [J]. Drug Metab Dispos, 1999,27 (10): 1143-1149. 被引量:1
  • 3Csajka C, Buclin T,Bruner HR. Pharmakenatic-pharmaeodynamic profile of angiotensin. H receptor antagonists [J]. Clin pharmacokinet, 1997,32 ( 1 ): 1-29. 被引量:1
  • 4Neutel JM, Klein C, Meinicke TU,et al. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications [ J ]. Blood Press ,2002,11 ( 5 ): 302-309. 被引量:1

同被引文献26

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部